Biogen (NASDAQ:BIIB) Releases FY24 Earnings Guidance

Biogen (NASDAQ:BIIB – Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $15.00-16.00 for the period, compared to the consensus earnings per share estimate of $15.49. The company issued revenue guidance of decline low- to mid-single digits, compared to the consensus revenue […]

Related Keywords

Canada ,United States ,Germany ,William Blair ,Priya Singhal ,Erick Rowinsky ,Biogen Inc ,Biogen Company Profile ,Royal Bank ,Securities Exchange Commission ,Wells Fargo Company ,Jpmorgan Chase Co ,Get Free Report ,Moderate Buy ,Exchange Commission ,Director Eric ,Biogen Daily ,Biogen ,Nasdaq Biib ,Biib ,Medical ,09062x10 ,Guidance ,Earnings ,Preannouncement ,